Thomas Leggett - Net Worth and Insider Trading

Thomas Leggett Net Worth

The estimated net worth of Thomas Leggett is at least $0 dollars as of 2024-11-13. Thomas Leggett is the CFO of Black Diamond Therapeutics Inc and owns about 0 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $0. Details can be seen in Thomas Leggett's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Leggett has not made any transactions after 2021-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Thomas Leggett

To

Thomas Leggett Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Leggett owns 3 companies in total, including Black Diamond Therapeutics Inc (BDTX) , Axcella Health Inc (AXLA) , and Research Alliance Corp II (RACB) .

Click here to see the complete history of Thomas Leggett’s form 4 insider trades.

Insider Ownership Summary of Thomas Leggett

Ticker Comapny Transaction Date Type of Owner
BDTX Black Diamond Therapeutics Inc 2021-01-08 Chief Financial Officer
AXLA Axcella Health Inc 2019-05-08 SVP Finance & CFO
RACB Research Alliance Corp II 2021-03-17 director

Thomas Leggett Latest Holdings Summary

Thomas Leggett currently owns a total of 1 stock. Thomas Leggett owns 0 shares of Black Diamond Therapeutics Inc (BDTX) as of January 8, 2021, with a value of $0.

Latest Holdings of Thomas Leggett

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BDTX Black Diamond Therapeutics Inc 2021-01-08 0 3.24 0

Holding Weightings of Thomas Leggett


Thomas Leggett Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Leggett has made a total of 5 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Black Diamond Therapeutics Inc is the sale of 3,000 shares on January 8, 2021, which brought Thomas Leggett around $101,820.

Insider Trading History of Thomas Leggett

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Leggett Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Leggett Ownership Network

Ownership Network List of Thomas Leggett

No Data

Ownership Network Relation of Thomas Leggett

Insider Network Chart

Thomas Leggett Owned Company Details

What does Black Diamond Therapeutics Inc do?

Who are the key executives at Black Diamond Therapeutics Inc?

Thomas Leggett is the Chief Financial Officer of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , 10 percent owner Biotech Growth N V , and director & 10 percent owner Ali Behbahani .

Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary

Over the past 18 months, Thomas Leggett made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Black Diamond Therapeutics Inc Insider Transactions

No Available Data

Thomas Leggett Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Leggett. You might contact Thomas Leggett via mailing address: C/o Axcella Health Inc., 840 Memorial Drive, Cambridge Ma 02139.